Another peptide comprising eight amino acids that bind specifically to CD44 (375) and derived from human urokinase plasminogen activator (A6) inhibits migration, invasion, and metastasis of cancer cells by interfering with an uPA-independent signaling pathway (376). This evidence concerns the gene PLAU and cancer.